Goldstein Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$805K Buy
3,700
+142
+4% +$31.5K 0.09% 77
2025
Q4
$813K Buy
3,558
+321
+10% +$73.1K 0.09% 78
2025
Q3
$749K Sell
3,237
-115
-3% -$23.4K 0.09% 78
2025
Q2
$622K Sell
3,352
-2,124
-39% -$395K 0.08% 78
2025
Q1
$1.15M Buy
5,476
+156
+3% +$30.3K 0.17% 49
2024
Q4
$945K Hold
5,320
0.14% 58
2024
Q3
$1.05M Buy
5,320
+186
+4% +$34.7K 0.16% 50
2024
Q2
$881K Buy
5,134
+120
+2% +$19.9K 0.15% 52
2024
Q1
$913K Buy
5,014
+30
+0.6% +$5.17K 0.16% 53
2023
Q4
$772K Buy
4,984
+138
+3% +$20.1K 0.13% 82
2023
Q3
$722K Buy
4,846
+514
+12% +$75.5K 0.15% 55
2023
Q2
$584K Sell
4,332
-494
-10% -$72.4K 0.12% 67
2023
Q1
$769K Sell
4,826
-444
-8% -$67.9K 0.17% 56
2022
Q4
$852K Buy
+5,270
New +$808K 0.21% 51

Other funds holding ABBV